1. Home
  2. GBIO vs EUDA Comparison

GBIO vs EUDA Comparison

Compare GBIO & EUDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Generation Bio Co.

GBIO

Generation Bio Co.

HOLD

Current Price

$5.77

Market Cap

36.3M

Sector

Health Care

ML Signal

HOLD

Logo EUDA Health Holdings Limited

EUDA

EUDA Health Holdings Limited

HOLD

Current Price

$2.35

Market Cap

68.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
GBIO
EUDA
Founded
2016
2021
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
36.3M
68.7M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
GBIO
EUDA
Price
$5.77
$2.35
Analyst Decision
Buy
Analyst Count
5
0
Target Price
$8.88
N/A
AVG Volume (30 Days)
65.6K
656.7K
Earning Date
11-05-2025
12-19-2023
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.01
Revenue
$15,270,000.00
$5,160,280.00
Revenue This Year
N/A
$137.25
Revenue Next Year
N/A
$361.43
P/E Ratio
N/A
$321.86
Revenue Growth
N/A
83.73
52 Week Low
$3.00
$1.03
52 Week High
$12.40
$4.70

Technical Indicators

Market Signals
Indicator
GBIO
EUDA
Relative Strength Index (RSI) 60.89 47.73
Support Level $5.40 $1.21
Resistance Level $5.69 $2.70
Average True Range (ATR) 0.22 0.51
MACD 0.04 0.00
Stochastic Oscillator 87.72 64.00

Price Performance

Historical Comparison
GBIO
EUDA

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About EUDA EUDA Health Holdings Limited

EUDA Health Holdings Ltd is a non-invasive healthcare company across Southeast Asia and China. The Company has two reportable segments: property management services and holistic wellness consumer products and services. Key revenue is generated from property management services that include common area property management services that contain cleaning, landscaping, public facilities maintenance and other traditional services and also include security property management services provided to all tenants and property owners.

Share on Social Networks: